Page 3 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Analyst Today - Breaking & Trending Today

GlobalData : Early diagnosis continues to pose challenges for Parkinson's disease-modifying therapies, says GlobalData -March 11, 2024 at 10:19 am EDT

11 Mar, 2024 Early diagnosis continues to pose challenges for Parkinson s disease-modifying therapies, says GlobalData

Share

. ....

Christie Wong , International Conference On Alzheimer , Pharma Analyst , Drug Database ,

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sasmitha Sahu , Memorial Sloan Kettering Cancer Center , Globaldata Pharma Intelligence Center Drugs , Noile Immune Biotech , Crescendo Biologics , Pharma Analyst ,

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData ....

Sasmitha Sahu , Memorial Sloan Kettering Cancer Center , Globaldata Pharma Intelligence Center Drugs , Noile Immune Biotech , Crescendo Biologics , Pharma Analyst ,

Otsuka's new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData - Pharma News

Otsuka's new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Abilify Asimtufii , Eleni Tokali , Abilify Maintena , Abilify Maintena Aripiprazole , Otsuka Pharmaceutical , Drugs Database , Pharma Analyst ,

Otsuka's new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData

Otsuka Pharmaceutical is poised for a strategic transition as it approaches the loss of market exclusivity of Abilify Maintena (Aripiprazole) in Europe and the US in October 2024. This significant development signals a forthcoming shift in the drug’s sales trajectory, highlighting Otsuka’s readiness to embrace . ....

Abilify Maintena , Abilify Asimtufii , Abilify Maintena Aripiprazole , Eleni Tokali , Otsuka Pharmaceutical , Drugs Database , Pharma Analyst ,